Position in PHVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$49,437,500
+$875,000 QoQ
Shares Held
1,750,000
0.0% QoQ
Ownership
2.50%
of shares outstanding
% of Portfolio
3.99%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NOVO HOLDINGS A/S holds $857,300,211 across 16 Biotechnology names. PHVS ranks #7 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
5,350,000 | $168,525,000 | |
| 2 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,325,000 | $122,403,500 | |
| 3 | MPLT |
MapLight Therapeutics, Inc.
|
3,686,622 | $74,949,025 | |
| 4 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,550,000 | $56,296,000 | |
| 5 | ELVN |
Enliven Therapeutics, Inc.
|
1,280,000 | $50,176,000 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
860,000 | $49,974,600 | |
| 7 | PHVS |
Pharvaris N.V.
This page
|
1,750,000 | $49,437,500 | |
| 8 | AVBP |
ArriVent BioPharma, Inc.
|
1,942,142 | $44,805,215 |
All Filings in PHVS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $49,437,500 | 1,750,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $48,562,500 | 1,750,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $43,662,500 | 1,750,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $30,360,000 | 1,725,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $27,082,500 | 1,725,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $33,068,250 | 1,725,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $31,947,000 | 1,725,000 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $32,430,000 | 1,725,000 | Shares | Sole | 2024-08-20 | |
| 2024-03-31 | $26,993,173 | 1,168,030 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $43,178,066 | 1,539,325 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $27,743,012 | 1,329,325 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $20,125,980 | 1,329,325 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $10,707,712 | 1,329,325 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $13,357,203 | 1,187,307 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,678,700 | 610,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,477,391 | 519,339 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,363,481 | 516,321 | Shares | Sole | 2022-05-27 | |
| 2021-12-31 | $7,429,859 | 516,321 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,427,859 | 418,943 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,070,612 | 111,144 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,399,000 | 50,000 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||